Ovarian Cancer

Oxford University researchers have found a way to detect ovarian cancer early and identified an enzyme that is key in making ovarian cancer more deadly. Their results, published in two journals, provide new research routes for scientists trying to detect and beat the disease.

Online information about ovarian cancer can cause as much worry as comfort for women at high risk of developing the disease, researchers in the School of Medicine have found.

Drop level from 10% risk to 4% to extend lives of more women, say researchers.

Results Show Survival Benefit of Surgery for Patients Regardless of Age or Advanced Disease, and Point to Barriers to Cancer Care Delivery

Nearly 70 percent of ovarian cancer cases are detected after metastasis, which is the development of secondary malignant growths distant from the primary site of cancer. Understanding ovarian cancer metastasis is a research focus of M. Sharon Stack, the Ann F. Dunne & Elizabeth Riley Director of the Harper Cancer Research Institute (HCRI) and Kleiderer-Pezold Professor of Chemistry and Biochemistry at the University of Notre Dame.

Testing Non-Breast/Ovarian Cancer Genes in High-Risk Women Leaves More Questions than Answers, Penn Study Finds
Expanding gene panel beyond breast/ovarian cancer genes did not add clinical benefit

Expanding gene panel beyond breast/ovarian cancer genes did not add clinical benefit